Peter Hoang
2021
In 2021, Peter Hoang earned a total compensation of $1.6M as President and Chief Executive Officer at TapImmune, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,043 |
|---|---|
| Option Awards | $1,001,900 |
| Salary | $424,089 |
| Total | $1,619,032 |
Hoang received $1M in option awards, accounting for 62% of the total pay in 2021.
Hoang also received $193K in non-equity incentive plan and $424.1K in salary.
Rankings
In 2021, Peter Hoang's compensation ranked 6,921st out of 12,415 executives tracked by ExecPay. In other words, Hoang earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,921 out of 12,415 | 44th |
Division Manufacturing | 3,022 out of 5,501 | 45th |
Major group Chemicals And Allied Products | 1,338 out of 2,371 | 44th |
Industry group Drugs | 1,194 out of 2,092 | 43rd |
Industry Pharmaceutical Preparations | 869 out of 1,542 | 44th |
Source: SEC filing on April 15, 2022.
Hoang's colleagues
We found two more compensation records of executives who worked with Peter Hoang at TapImmune in 2021.